LMU 267 – Metformin Shown to Double Risk of Dementia and Parkinson’s Disease in Large, 12-year Study with Type 2 Diabetics
Metformin Shown to Double Risk of Dementia and Parkinson’s Disease in Large, 12-year Study with Type 2 DiabeticsSource: 13th International Conference on Alzheimer’s and Parkinson’s disease (Abstract 312), presented on March 29, 2017, and reviewed in the December 5, 2022, Medscape ArticleLifestyle Medicine Update (December 6, 2022)A very popular drug in the management of type Read More